Dr. Gustavo A. Moviglia, director técnico de LYRACELL y creador del Método Moviglia
Medical and scientific leadership

Dr. Gustavo A. Moviglia

Technical Direction · Research and Development Advisor

Physician and researcher in immunology and cell therapy, with more than four decades of experience in Argentina and the United States. He leads the technical operations of the LYRACELL laboratory and the research lines of the Moviglia Method.

Cell therapyImmunologyRegenerative medicineTranslational research
Career
+
0
years of medical and scientific career
+
0
peer-reviewed scientific publications
0
patent applications in cell therapy and immunotherapy
Biography

More than four decades in immunology and cell therapy.

Dr. Gustavo A. Moviglia earned his medical degree from the School of Medicine of the National University of La Plata and his PhD from Maimónides University, with a thesis on the foundations of a rational, integrated immunotherapy for advanced breast cancer. He trained as a CONICET fellow in cell biology at the National University of Cuyo and at Wayne State University (Detroit, United States).

He developed cell immunotherapies for cancer, autoimmune and neuroimmune diseases. He was Medical Director of Immunotherapy and Regenerative Medicine at Instituto Regina Mater and, between 2007 and 2019, Director of the Tissue Engineering and Cell Therapy Research Center at Maimónides University, where he was also Professor of Immunology and Cell Therapy. His line of research showed that tissue-specific effector lymphocytes can guide the differentiation of mesenchymal stem cells into progenitors of the tissue to be repaired.

Since 2019 he has been an Associate Professor at the Wake Forest Institute for Regenerative Medicine (United States). He is Executive Director of ACIDTA and designed the institution’s advanced therapy medicinal products manufacturing laboratory and its quality management manual, in accordance with ANMAT regulations.

Scientific recognition

An international reference in cell therapy.

Science Advances · 2023He is a co-author of the study “The synovial environment steers cartilage deterioration and regeneration” (Bolander, J. et al.), developed together with the Wake Forest Institute for Regenerative Medicine.

International societiesHe was Vice President for Central and South America of the International Society for Cellular Therapy (ISCT) and International President of the International Association of Neurorestoratology (2017–2018), on whose board he serves.

Regulation · ANMATBetween 2011 and 2018 he served as a regulatory advisor in drafting the ANMAT regulations that recognize cell therapy as a medicinal product and set the requirements for its laboratories and clinical trials.

Publications and patentsHe is the author of more than 20 peer-reviewed publications in journals such as Cytotherapy, Spinal Cord and Cell Transplantation, as well as patent applications on cell therapies, and he serves on the editorial board of the Journal of Neurorestoratology.

View the full research →

Your next step

Request a medical evaluation.

The LYRACELL medical team defines the most suitable approach based on your diagnosis.